StartDate,EndDate,Status,IPAddress,Progress,Duration (in seconds),Finished,RecordedDate,ResponseId,RecipientLastName,RecipientFirstName,RecipientEmail,ExternalReference,LocationLatitude,LocationLongitude,DistributionChannel,UserLanguage,Q1,Q17,Q15,Q7,Q8,Q9,Q10,Q11,Q12,Q13,Q14,Q18,11,Login ID
Start Date,End Date,Response Type,IP Address,Progress,Duration (in seconds),Finished,Recorded Date,Response ID,Recipient Last Name,Recipient First Name,Recipient Email,External Data Reference,Location Latitude,Location Longitude,Distribution Channel,User Language,Name of Key Program,Acronym for key program,Focus Area (select all that apply),DOC,Primary Contact (PI),Primary Contact (PI) email,NIH Contact (Program Officer/Program Director),NIH Contact (Program Officer/Program Director) email,"NOFO number (eg. format as ""RFA-CA-00-000"") (If more than one, separate with ; semicolon)","Grant/Award number {parent award FORMAT LL#CA######, eg. UG3CA260607} (If more than one, separate with ; semicolon)",Link to program website,Link to data or DCC if available,"What type of cancer is the primary focus of the program? (Check all that
apply)",Login ID
"{""ImportId"":""startDate"",""timeZone"":""America/Denver""}","{""ImportId"":""endDate"",""timeZone"":""America/Denver""}","{""ImportId"":""status""}","{""ImportId"":""ipAddress""}","{""ImportId"":""progress""}","{""ImportId"":""duration""}","{""ImportId"":""finished""}","{""ImportId"":""recordedDate"",""timeZone"":""America/Denver""}","{""ImportId"":""_recordId""}","{""ImportId"":""recipientLastName""}","{""ImportId"":""recipientFirstName""}","{""ImportId"":""recipientEmail""}","{""ImportId"":""externalDataReference""}","{""ImportId"":""locationLatitude""}","{""ImportId"":""locationLongitude""}","{""ImportId"":""distributionChannel""}","{""ImportId"":""userLanguage""}","{""ImportId"":""QID1_TEXT""}","{""ImportId"":""QID17_TEXT""}","{""ImportId"":""QID15""}","{""ImportId"":""QID7""}","{""ImportId"":""QID8_TEXT""}","{""ImportId"":""QID9_TEXT""}","{""ImportId"":""QID10_TEXT""}","{""ImportId"":""QID11_TEXT""}","{""ImportId"":""QID12_TEXT""}","{""ImportId"":""QID13_TEXT""}","{""ImportId"":""QID14_TEXT""}","{""ImportId"":""QID18_TEXT""}","{""ImportId"":""QID16""}","{""ImportId"":""Login ID""}"
7/18/2023 14:30,7/18/2023 14:41,IP Address,73.130.95.160,100,680,TRUE,7/18/2023 14:41,R_b29WNmDDM4Nhd7j,,,,,40.0756,-76.6914,anonymous,EN,The Early Detection Research Network (EDRN),EDRN,"DCC,Clinical Networks",DCP,,,"MARQUEZ, GUILLERMO; SORBARA, LYNN R",gm186p@nih.gov; lynns@mail.nih.gov,CA-14-017;CA-21-034;CA-21-033;CA-21-035;CA-14-015;CA-14-016;CA-16-009,,https://edrn.nci.nih.gov/,https://edrn.nci.nih.gov/data-and-resources/data/,This program focuses on cancer broadly - not limited to a primary cancer type,190484
7/18/2023 14:43,7/18/2023 14:44,IP Address,73.130.95.160,100,43,TRUE,7/18/2023 14:44,R_0pT1g50QqcEx2VP,,,,,40.0756,-76.6914,anonymous,EN,Cancer Prevention-Interception Targeted Agent Discovery Program,CAP-IT,DCC,DCP,,,"Sei, Shizuko",shizuko.sei@nih.gov,RFA-CA-21-038;RFA-CA-22-055;RFA-CA-21-039,,https://prevention.cancer.gov/major-programs/cancer-prevention-interception-targeted-agent-discovery-program,,This program focuses on cancer broadly - not limited to a primary cancer type,556874
7/27/2023 6:27,7/27/2023 6:52,IP Address,73.130.95.160,100,1497,TRUE,7/27/2023 6:52,R_1ITd7QI7z9Pv4CM,,,,,40.0756,-76.6914,anonymous,EN,Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS),ACCSIS,"DCC,Cancer Moonshot",DCCPS,,,"GRIMES, GENEVIEVE M",medleyge@mail.nih.gov,CA17-039;CA-17-038;CA-19-018,,https://healthcaredelivery.cancer.gov/accsis/,https://accsis.rti.org/consortium/cc/,Colorectal Cancer,896721
7/31/2023 9:31,7/31/2023 10:44,IP Address,128.231.234.20,100,4398,TRUE,7/31/2023 10:44,R_1BVldgCxHAnJ4iJ,,,,,39.0462,-77.1195,anonymous,EN,Genomic Data Analysis Network,GDAN,DCC,CCG,,,"LIMING, YANG",lyang@mail.nih.gov,RFA-CA-20-053; RFA-CA-15-020; RFA-CA-15-019; RFA-CA-15-018,,https://docs.gdc.cancer.gov/Encyclopedia/pages/Genomic_Data_Analysis_Network/,,This program focuses on cancer broadly - not limited to a primary cancer type,418400
8/1/2023 5:38,8/1/2023 5:40,IP Address,73.130.95.160,100,108,TRUE,8/1/2023 5:40,R_OjyS5M37C165F7j,,,,,40.0756,-76.6914,anonymous,EN,Development and Expansion of Digital Tools to Support Smoking Cessation,C3I,Cancer Moonshot,DCCPS,,,"Vandor, Stacey",vandors@mail.nih.gov,,26114002B91019F00132-0-0-1,https://cancercontrol.cancer.gov/brp/tcrb/cancer-center-cessation-initiative,,This program focuses on cancer broadly - not limited to a primary cancer type,720371
8/1/2023 5:40,8/1/2023 7:24,IP Address,73.130.95.160,100,6270,TRUE,8/1/2023 7:24,R_XvyAFR3tOX4II9z,,,,,40.0756,-76.6914,anonymous,EN,THE CHERNOBYL TISSUE BANK - COORDINATING CENTER,THE CHERNOBYL TISSUE BANK - COORDINATING CENTER,"DCC,Clinical Networks",DCEG,,,"YASSIN, RIHAB R.",ry38k@nih.gov,CA16-502;CA12-501,,https://www.chernobyltissuebank.com/,,Thyroid Cancer,190427
8/2/2023 12:56,8/2/2023 12:58,IP Address,128.231.234.26,100,124,TRUE,8/2/2023 12:58,R_21tzV4xoiX11RWm,,,,,39.0462,-77.1195,anonymous,EN,Cancer Prevention Clinical Trials Network (CP-CTNet),CP-CTNet,"DCC,Clinical Networks",DCP,,,"JOHNSEY, DONALD",dj156d@nih.gov,CA-18-030;CA-18-029;CA-19-031,,https://prevention.cancer.gov/major-programs/cancer-prevention-clinical-trials-network-cp-ctnet,https://www.cp-ctnet-dmacc.org/public/program-resources/,This program focuses on cancer broadly - not limited to a primary cancer type,204710
8/3/2023 10:27,8/3/2023 12:13,IP Address,128.231.234.23,100,6347,TRUE,8/3/2023 12:13,R_1esL0DW3fEZp3k3,,,,,39.0462,-77.1195,anonymous,EN,Co-Clinical Imaging Research Resource Program,CIRP,"Cancer Moonshot,Clinical Networks",DCTD,,,"ZHANG, HUIMING",zhanghui@mail.nih.gov,PAR-18-841;PAR-16-385;PAR-15-266,,https://ncihub.cancer.gov/groups/cirphub/overview,,This program focuses on cancer broadly - not limited to a primary cancer type,439844
8/7/2023 7:51,8/7/2023 7:52,IP Address,73.130.95.160,100,68,TRUE,8/7/2023 7:52,R_33kbsTWRiHV0EX4,,,,,40.0756,-76.6914,anonymous,EN,The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials (ALCHEMIST),ALCHEMIST,Clinical Networks,DCTD,,,"MOONEY, MARGARET M",mooneym@mail.nih.gov,,U10CA180821;U10CA180830;U10CA031946,https://www.cancer.gov/types/lung/research/alechmist-launch-qa,,Lung Cancer,736643
8/30/2023 12:05,8/30/2023 12:06,IP Address,128.231.234.1,100,14,TRUE,8/30/2023 12:06,R_4N1XriaiDT3au9r,,,,,39.0042,-77.1075,anonymous,EN,Cancer Immunologic Data Commons,CIDC,Cancer Moonshot,DCTD,"CERAMI, ETHAN",cerami@jimmy.harvard.edu,"THURIN, MAGDALENA",thurinm@mail.nih.gov,RFA-CA-17-006; RFA-CA-22-038,,https://dctd.cancer.gov/ResearchNetworks/cimacs_cidc_network.html,,This program focuses on cancer broadly - not limited to a primary cancer type,267552
8/29/2023 5:13,8/30/2023 13:09,IP Address,128.231.234.1,100,114967,TRUE,8/30/2023 13:09,R_xr7mFOV47zMcVLX,,,,,39.0042,-77.1075,anonymous,EN,The Experimental Therapeutics Clinical Trials Network ,ETCTN,"DCC,Clinical Networks",DCTD,,,"IVY, S PERCY",ivyp@ctep.nci.nih.gov,CA19-008;CA19-007;CA15-501;CA-13-006;CA-07-031;CA-02-011,,https://ctep.cancer.gov/initiativesprograms/etctn.htm,,This program focuses on cancer broadly - not limited to a primary cancer type,339909
11/16/2023 5:59,11/16/2023 6:26,IP Address,156.40.252.1,100,1633,TRUE,11/16/2023 6:26,R_1DN2Em0irVCTxHH,,,,,39.0015,-77.0961,anonymous,EN,Implementation Science Centers in Cancer Control ,ISC3,Cancer Moonshot,DCCPS,,,"VINSON, CYNTHIA",cynthia.vinson@nih.gov,RFA-CA-19-005;RFA-CA-19-006,,https://iscentersincancercontrol.org/,,This program focuses on cancer broadly - not limited to a primary cancer type,732131
12/28/2023 9:23,12/28/2023 9:23,IP Address,73.130.95.160,100,27,TRUE,12/28/2023 9:23,R_73yzMNL2fZGUJYN,,,,,40.1025,-76.0761,anonymous,EN, Small Cell Lung Cancer (SCLC) Consortium ,SCLC,DCC,DCP,,,"UJHAZY, PETER",ujhazyp@mail.nih.gov,PAR21-346;PAR-16-049;PAR-16-050;PAR-16-051;PAR-19-361,,https://prevention.cancer.gov/major-programs/small-cell-lung-cancer-sclc-consortium,https://www.mskcc.org/research-programs/nci-small-cell-lung-cancer-consortium/cellminer-sclc,Lung Cancer,911580
12/28/2023 9:35,12/28/2023 9:36,IP Address,73.130.95.160,100,39,TRUE,12/28/2023 9:36,R_1r6W248cpZPWWPH,,,,,40.1025,-76.0761,anonymous,EN,Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer,SPORE - Gastrointestinal,SPORE,DCTD,,,"NOTHWEHR, STEVEN F",nothwehrs@mail.nih.gov,,P50CA127003,https://trp.cancer.gov/spores/abstracts/dfhcc_gi.htm,,"Gastric Cancer,SPORE",831710
12/28/2023 9:38,12/28/2023 9:38,IP Address,73.130.95.160,100,10,TRUE,12/28/2023 9:38,R_3jSYDo0uE4yBSAY,,,,,40.1025,-76.0761,anonymous,EN,HIV-Associated Malignancy Research Centers,HAMRCs,"HIV/AIDS,Health Disparities",OHAM,,,Geraldina Dominguez,domingug@mail.nih.gov,RFA-CA-20-001; RFA-CA-22-011,,https://www.cancer.gov/about-nci/organization/oham/hiv-aids-research/oham-research/research-africa,,"This program focuses on cancer broadly - not limited to a primary cancer type,HIV/AIDS",264663
12/28/2023 9:39,12/28/2023 9:39,IP Address,73.130.95.160,100,6,TRUE,12/28/2023 9:39,R_699W9jh6t0ezpuo,,,,,40.1025,-76.0761,anonymous,EN,AIDS and Cancer Specimen Resource (ACSR),ACSR,HIV/AIDS,OHAM,,,Rebecca Liddell Huppi,liddellr@mail.nih.gov,RFA-CA-18-012,,https://acsr1.com/,,HIV/AIDS,194679
12/28/2023 9:40,12/28/2023 9:40,IP Address,73.130.95.160,100,33,TRUE,12/28/2023 9:40,R_6lA2JF0qfI8wSJV,,,,,40.1025,-76.0761,anonymous,EN,Pancreatic Cancer Microenvironment Network,PaCMEN,"Cancer Moonshot,Clinical Networks",DCTD,,,"Ujhazy, Peter",ujhazyp@mail.nih.gov,RFA-CA-17-015; RFA-CA-17-016,,https://pacmen.org/,https://pacmen.org/Dbs.html,Pancreas Cancer,763469
12/28/2023 9:43,12/28/2023 9:43,IP Address,73.130.95.160,100,17,TRUE,12/28/2023 9:43,R_3C3zTbM9AFW47Ob,,,,,40.1025,-76.0761,anonymous,EN,Pediatric Preclinical in Vivo Testing (PIVOT) ,PIVOT,"Pediatric/AYA,DCC,Cancer Moonshot","CIB,CTEP,DCTD","BULT, CAROL J",carol.bult@jax.org,"Smith, Malcolm ",Malcolm.Smith@nih.gov,RFA-CA-20-034; RFA-CA-14-018; RFA-CA-20-041,,https://preclinicalpivot.org/,,"This program focuses on cancer broadly - not limited to a primary cancer type,Pediatric/AYA",204369
12/28/2023 9:44,12/28/2023 9:44,IP Address,73.130.95.160,100,16,TRUE,12/28/2023 9:44,R_6ZLo71x4mbMRgbv,,,,,40.1025,-76.0761,anonymous,EN,Oncology Models Forum (U24),OMF,"DCC,Cancer Moonshot",DCB,"BUTTE, ATUL J",atul.butte@ucsf.edu,Joanna Watson,watsonjo@mail.nih.gov,PAR14-239; PAR-16-059; PAR-17-245; PAR-20-131,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf,https://www.cancer.gov/about-nci/organization/dcb/research-programs/omf#nci-and-omf-resources-related-to-oncology-models,This program focuses on cancer broadly - not limited to a primary cancer type,819833
12/28/2023 9:45,12/28/2023 9:46,IP Address,73.130.95.160,100,38,TRUE,12/28/2023 9:46,R_3kn2xslKd5DbSPw,,,,,40.1025,-76.0761,anonymous,EN,Pancreatic Adenocarcinoma Stromal Reprograming ConSortium (PSRC/PASSCODE),PSRC,DCC,"DCB,DCTD","MAITRA, ANIRBAN",amaitra@mdanderson.org,"UJHAZY, PETER",ujhazyp@mail.nih.gov,RFA-CA-21-041; RFA-CA-21-042,,https://www.nci-psrc.org/index.html#Home,https://www.nci-psrc.org/team_MDACC.html,Pancreas Cancer,771645
12/28/2023 9:47,12/28/2023 9:47,IP Address,73.130.95.160,100,33,TRUE,12/28/2023 9:47,R_1DB075ENWpJRCAF,,,,,40.1025,-76.0761,anonymous,EN,Participant Engagement and Cancer Genome Sequencing,PE-CGS,Cancer Moonshot,DCCPS,,,"CHOU, WEN-YING",chouws@mail.nih.gov,CA19-046;CA19-045;,,https://pe-cgs.org/,,This program focuses on cancer broadly - not limited to a primary cancer type,287075
12/28/2023 9:48,12/28/2023 9:48,IP Address,73.130.95.160,100,19,TRUE,12/28/2023 9:48,R_7n7Z9jW0QVAcIxj,,,,,40.1025,-76.0761,anonymous,EN,Metabolic Dysregulation and Cancer Risk Program,Metabolic Dysregulation and Cancer Risk Program,"DCC,Clinical Networks","CRCHD,DCB,DCCPS,DCP",,,"LAM, TRAM K",lamt@mail.nih.gov,CA21-022;CA21-021,,https://medoc.bsc.gwu.edu/web/medoc,,This program focuses on cancer broadly - not limited to a primary cancer type,874349
12/28/2023 9:49,12/28/2023 9:50,IP Address,73.130.95.160,100,20,TRUE,12/28/2023 9:50,R_7xVCMWpRc6r538Z,,,,,40.1025,-76.0761,anonymous,EN,Cellular Senescence Network,SenNET,DCC,NIH/OD,,,"JHAPPAN, CHAMELLI",jhappanc@mail.nih.gov,RM21-010;RM21-009;RM21-008,,https://sennetconsortium.org/about-2/,https://data.sennetconsortium.org/search?size=n_10000_n&sort%5B0%5D%5Bfield%5D=last_modified_timestamp&sort%5B0%5D%5Bdirection%5D=desc,This program focuses on cancer broadly - not limited to a primary cancer type,255098
12/28/2023 9:54,12/28/2023 9:56,IP Address,73.130.95.160,100,114,TRUE,12/28/2023 9:56,R_1ZIyNeB5FNeykta,,,,,40.1025,-76.0761,anonymous,EN,PRE-medical Cancer Immunotherapy Network Canine Trials,PRECINCT,DCC,DCTD,,,"SOMMERS, CONNIE L",sommersc@mail.nih.gov,CA21-051;CA21-050,,https://www.precinctnetwork.org/,https://caninecommons.cancer.gov/#/,This program focuses on cancer broadly - not limited to a primary cancer type,580058
12/28/2023 9:57,12/28/2023 9:57,IP Address,73.130.95.160,100,15,TRUE,12/28/2023 9:57,R_5ccKt3QSAf70cn2,,,,,40.1025,-76.0761,anonymous,EN,ILLUMINATING THE DRUGGABLE GENOME,IDG,DCC,NIH/OD,,,"LI, JERRY",jerry.li@nih.gov,RM16-024;RM16-025;RM16-026,,https://commonfund.nih.gov/idg,https://druggablegenome.net/DataTools,This program focuses on cancer broadly - not limited to a primary cancer type,262219
12/28/2023 9:59,12/28/2023 9:59,IP Address,73.130.95.160,100,23,TRUE,12/28/2023 9:59,R_36T2NsKKDIxcIbT,,,,,40.1025,-76.0761,anonymous,EN,Translational and Basic Science Research in Early Lesions,TBEL,DCC,"DCB,DCP",,,"PATRIOTIS, CHRISTOS F",patriotisc@mail.nih.gov,CA21-055;CA21-054,,https://www.tbelprogram.org/index.html,,This program focuses on cancer broadly - not limited to a primary cancer type,260770
12/28/2023 10:23,12/28/2023 10:24,IP Address,73.130.95.160,100,84,TRUE,12/28/2023 10:24,R_7UKAc8s0r3TX7H3,,,,,40.1025,-76.0761,anonymous,EN,Cancer Genome Characterization Initiative,CGCI,DCC,CCG,,,"Komschlies Mcconvill, Kristin",komschkr@mail.nih.gov,,261200800001E-52-0-113;261201500003I-0-26100065-1 ,https://www.cancer.gov/ccg/research/genome-sequencing/cgci,https://portal.gdc.cancer.gov/exploration?filters=%7B%22op%22%3A%22and%22%2C%22content%22%3A%5B%7B%22op%22%3A%22in%22%2C%22content%22%3A%7B%22field%22%3A%22cases.project.program.name%22%2C%22value%22%3A%5B%22CGCI%22%5D%7D%7D%5D%7D,This program focuses on cancer broadly - not limited to a primary cancer type,326410
12/28/2023 10:26,12/28/2023 10:26,IP Address,73.130.95.160,100,6,TRUE,12/28/2023 10:26,R_1MFscAOpFHS9Dqx,,,,,40.1025,-76.0761,anonymous,EN,HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network,CASCADE,"HIV/AIDS,DCC,Clinical Networks",DCP,,,"Sahasrabuddhe, Vikrant",vikrant.sahasrabuddhe@nih.gov,CA-21-045;CA-21-046;CA-21-047;CA-22-051,,https://prevention.cancer.gov/major-programs/hiv-cervical-cancer-prevention-cascade-clinical-trials-network,,"Cervical Cancer,HIV/AIDS",838706
12/28/2023 10:26,12/28/2023 10:28,IP Address,73.130.95.160,100,103,TRUE,12/28/2023 10:28,R_3qTLqV7JyBSQnZi,,,,,40.1025,-76.0761,anonymous,EN,Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer,SPORE - Breast Cancer - DF/HCC,SPORE,DCTD,,,"BASA JANAKIRAM, NAVEENA",naveena.basajanakiram@nih.gov,,P50CA168504,https://trp.cancer.gov/spores/abstracts/dfhcc_breast.htm,,"Breast Cancer,SPORE",346541
12/28/2023 10:29,12/28/2023 10:30,IP Address,73.130.95.160,100,10,TRUE,12/28/2023 10:30,R_6oZ6qWlPlrBBZO6,,,,,40.1025,-76.0761,anonymous,EN,Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant,SPORE Ovarian Cancer - DF/HCC,SPORE,DCTD,,,"BASA JANAKIRAM, NAVEENA",naveena.basajanakiram@nih.gov,,P50CA240243,https://trp.cancer.gov/spores/abstracts/dfhcc_ovarian.htm,,"Ovarian Cancer,SPORE",927418
12/28/2023 10:33,12/28/2023 10:33,IP Address,73.130.95.160,100,19,TRUE,12/28/2023 10:33,R_1jVq9N9ak8tjzIG,,,,,40.1025,-76.0761,anonymous,EN,CANCER IMMUNE MONITORING AND ANALYSIS CENTERS,CIMAC,Cancer Moonshot,"CTEP,DCTD",,,"Thurin, Magdalena",thurinm@mail.nih.gov,RFA-CA-17-005;RFA-CA-22-038,,https://dctd.cancer.gov/ResearchNetworks/cimacs_cidc_network.htm,,This program focuses on cancer broadly - not limited to a primary cancer type,211231
12/28/2023 10:35,12/28/2023 10:35,IP Address,73.130.95.160,100,6,TRUE,12/28/2023 10:35,R_7Bksye2LxaGjd7M,,,,,40.1025,-76.0761,anonymous,EN,City of Hope Lymphoma SPORE,SPORE - Lymphoma,SPORE,DCTD,,,"kuzmin, Igor",kuzmini@mail.nih.gov,,P50CA107399,https://www.cityofhope.org/research/hematologic-malignancies-research-institute/lymphoma-spore,,"Lymphoma,SPORE",692098
12/28/2023 10:37,12/28/2023 10:40,IP Address,73.130.95.160,100,161,TRUE,12/28/2023 10:40,R_7ozRLNyxLy8Btij,,,,,40.1025,-76.0761,anonymous,EN,Connecting Underrepresented Populations to Clinical Trials (CUSP2CT),CUSP2CT,"DCC,Health Disparities",CRCHD,,,"Stewart, Whitney; San Miguel-Majors, Sandra L. ",whitney.barfield@nih.gov,RFA-CA-21-063; RFA-CA-21-058; RFA-CA-22-014,,https://www.cancer.gov/about-nci/organization/crchd/inp/cusp2ct,,"This program focuses on cancer broadly - not limited to a primary cancer type,Health Disparities",141372
12/28/2023 10:40,12/28/2023 10:41,IP Address,73.130.95.160,100,22,TRUE,12/28/2023 10:41,R_6cUZEy6dHWBqxqN,,,,,40.1025,-76.0761,anonymous,EN,Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes,ENICTO,"DCC,Clinical Networks",DCCPS,"Evans, Scott; Robien, Kim",sevans@bsc.gwu.edu; krobien@gwu.edu,"Perna, Frank; Agurs-Collins, Tanya",pernafm@mail.nih.gov,RFA-CA-21-032; RFA-CA-21-031,,https://enicto.bsc.gwu.edu/web/enicto,https://enicto.bsc.gwu.edu/web/enicto/coordinating-center,This program focuses on cancer broadly - not limited to a primary cancer type,625761
12/28/2023 10:42,12/28/2023 10:43,IP Address,73.130.95.160,100,33,TRUE,12/28/2023 10:43,R_7dWHjxGO7j8e6KR,,,,,40.1025,-76.0761,anonymous,EN,Cancer Systems Biology Consortium (CSBC),CSBC,"DCC,Clinical Networks",DCB,,,"Dueck, Hannah; Zamisch, Monica; HUGHES, SHANNON K",hannah.dueck@nih.gov,RFA-CA-15-015; RFA-CA-21-049; RFA-CA-21-048; RFA-CA-15-014; PAR-16-131; PAR-19-287,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/csbc,https://www.cancercomplexity.synapse.org/,This program focuses on cancer broadly - not limited to a primary cancer type,626289
12/28/2023 10:47,12/28/2023 10:47,IP Address,73.130.95.160,100,28,TRUE,12/28/2023 10:47,R_5h6pztfFEHoJc0d,,,,,40.1025,-76.0761,anonymous,EN,A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research,CIBMTR (Data Resource),"DCC,Clinical Networks",DCTD,,,"HOROWITZ, MARY MARESCA",marymh@mcw.edu,CA-12-503;CA-17-031;CA-22-026,,https://cibmtr.org/,https://cibmtr.org/CIBMTR/Resources/Publicly-Available-Datasets#,"This program focuses on cancer broadly - not limited to a primary cancer type,Leukemia,Lymphoma",408821
12/28/2023 10:49,12/28/2023 10:50,IP Address,73.130.95.160,100,70,TRUE,12/28/2023 10:50,R_6jrnrQz76adixtJ,,,,,40.1025,-76.0761,anonymous,EN,Pancreatic Cancer Detection Consortium,PCDC,"DCC,Cancer Moonshot",DCP,,,"UJHAZY, PETER",ujhazyp@mail.nih.gov,CA-17-015;CA-17-016,,https://prevention.cancer.gov/major-programs/pancreatic-cancer-detection-consortium-pcdc,https://prevention.cancer.gov/major-programs/pancreatic-cancer-detection-consortium-pcdc/pcdc-resources-and-collaborative-opportunities,Pancreas Cancer,534166
12/28/2023 10:51,12/28/2023 10:51,IP Address,73.130.95.160,100,11,TRUE,12/28/2023 10:51,R_5IFwab86ZkCog5j,,,,,40.1025,-76.0761,anonymous,EN,Improving Management of Symptoms Across Cancer Treatments,IMPACT,"DCC,Cancer Moonshot,Clinical Networks",DCCPS,,,"ADAMS, LYNN S",lynn.adams@nih.gov,CA17-043;CA-17-042,,https://impactconsortium.rti.org/,,This program focuses on cancer broadly - not limited to a primary cancer type,523997
12/28/2023 10:52,12/28/2023 10:53,IP Address,73.130.95.160,100,8,TRUE,12/28/2023 10:53,R_7gzQUZBTxjUtCyl,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Gastrointestinal Cancers,SPORE Gastrointestinal Cancer - JHU,SPORE,DCTD,,,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA062924,https://trp.cancer.gov/spores/abstracts/johnshopkins_gi.htm,,"Gastric Cancer,SPORE",205473
12/28/2023 10:53,12/28/2023 10:53,IP Address,73.130.95.160,100,5,TRUE,12/28/2023 10:53,R_7HSd8QYXRP2xtn3,,,,,40.1025,-76.0761,anonymous,EN,Epigenetic Therapies - New Approaches,SPORE Epigenetics,SPORE,DCTD,,,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA254897,https://trp.cancer.gov/spores/abstracts/coriell_institute_epigenetics.htm,,"This program focuses on cancer broadly - not limited to a primary cancer type,SPORE",764553
12/28/2023 10:54,12/28/2023 10:54,IP Address,73.130.95.160,100,12,TRUE,12/28/2023 10:54,R_7lYzOTxZgBzml57,,,,,40.1025,-76.0761,anonymous,EN,Emory University Lung Cancer SPORE,SPORE Lung Cancer - Emory,SPORE,DCTD,,,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA217691,https://trp.cancer.gov/spores/abstracts/emory_lung.htm,,"Lung Cancer,SPORE",309827
12/28/2023 10:55,12/28/2023 10:55,IP Address,73.130.95.160,100,8,TRUE,12/28/2023 10:55,R_3t6u8c5AjdALJAJ,,,,,40.1025,-76.0761,anonymous,EN,MSK SPORE in Genomic Instability in Breast Cancer,SPORE Breast Cancer - MSK,SPORE,DCTD,,,"BASA JANAKIRAM, NAVEENA",naveena.basajanakiram@nih.gov,,P50CA247749,https://trp.cancer.gov/spores/abstracts/mskcc_breast.htm,,"Breast Cancer,SPORE",528130
12/28/2023 10:55,12/28/2023 10:57,IP Address,73.130.95.160,100,69,TRUE,12/28/2023 10:57,R_7rIGy7Rv5cwVUqs,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Breast Cancer,SPORE Breast Cancer - Vanderbilt,SPORE,DCTD,,,"COURTNEY, JOYANN",joyann.rohan@nih.gov,,P50CA098131,https://trp.cancer.gov/spores/abstracts/vanderbilt_breast.htm,,"Breast Cancer,SPORE",134835
12/28/2023 10:57,12/28/2023 10:58,IP Address,73.130.95.160,100,37,TRUE,12/28/2023 10:58,R_5PgIRYcVsXHXOD9,,,,,40.1025,-76.0761,anonymous,EN,University of North Carolina SPORE in Breast Cancer,SPORE Breast Cancer - UNC,SPORE,DCTD,,,"COURTNEY, JOYANN",joyann.rohan@nih.gov,,P50CA058223,https://trp.cancer.gov/spores/abstracts/unc_breast.htm,,"Breast Cancer,SPORE",767036
12/28/2023 10:58,12/28/2023 10:59,IP Address,73.130.95.160,100,19,TRUE,12/28/2023 10:59,R_3lrC07go34IN7Gx,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Lung Cancer - The University of Texas MD Anderson Cancer Center ,SPORE Lung Cancer - Texas,SPORE,DCTD,,,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA070907,https://trp.cancer.gov/spores/abstracts/utsouthwestern_lung.htm,,"Lung Cancer,SPORE",618842
12/28/2023 11:00,12/28/2023 11:00,IP Address,73.130.95.160,100,18,TRUE,12/28/2023 11:00,R_3gwj2Sc9OZLse3Y,,,,,40.1025,-76.0761,anonymous,EN,Dana-Farber/Harvard Cancer Center Kidney Cancer SPORE,SPORE Kidney Cancer - DF/HCC,SPORE,DCTD,,,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA101942,https://trp.cancer.gov/spores/abstracts/dfhcc_gu.htm,,"Kidney Cancer,SPORE",823948
12/28/2023 11:01,12/28/2023 11:01,IP Address,73.130.95.160,100,27,TRUE,12/28/2023 11:01,R_6MuqQYGy8Gh6cUC,,,,,40.1025,-76.0761,anonymous,EN,Mayo Clinic Hepatobiliary SPORE,SPORE Liver - Mayo Clinic,SPORE,DCTD,,,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA210964,https://trp.cancer.gov/spores/abstracts/mayo_hepatobiliary.htm,,"Liver Cancer,SPORE",869948
12/28/2023 11:02,12/28/2023 11:02,IP Address,73.130.95.160,100,12,TRUE,12/28/2023 11:02,R_3D0XfljdGoDZTe0,,,,,40.1025,-76.0761,anonymous,EN,Specialized Program Of Research Excellence (SPORE) in Leukemia.,SPORE Leukemia - WUSTL,SPORE,DCTD,,,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA171963,https://trp.cancer.gov/spores/abstracts/wustl_leukemia.htm,,"Leukemia,SPORE",148629
12/28/2023 11:03,12/28/2023 11:03,IP Address,73.130.95.160,100,20,TRUE,12/28/2023 11:03,R_5M6OFKMiAAjk6QF,,,,,40.1025,-76.0761,anonymous,EN,SPORE for Translational Approaches to Brain Cancer,SPORE Brain Cancer - Northwestern,SPORE,DCTD,,,"Hubbard, Leah",leah.hubbard@nih.gov,,P50CA221747,https://trp.cancer.gov/spores/abstracts/northwestern_brain.htm,,"Brain Cancer,SPORE",376423
12/28/2023 11:03,12/28/2023 11:04,IP Address,73.130.95.160,100,37,TRUE,12/28/2023 11:04,R_3HoEZy2Faeb4Kxo,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Brain Cancer  - The University of Texas MD Anderson Cancer Center ,SPORE Brain Cancer - Texas,SPORE,DCTD,,,"Hubbard, Leah",leah.hubbard@nih.gov,,P50CA127001,https://trp.cancer.gov/spores/abstracts/mdanderson_brain.htm,,"Brain Cancer,SPORE",887632
12/28/2023 11:05,12/28/2023 11:05,IP Address,73.130.95.160,100,28,TRUE,12/28/2023 11:05,R_3eLYFH2ly0m8fh7,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Gastrointestinal Cancer - The University of Texas MD Anderson Cancer Center,SPORE Gastrointestinal Cancer - MDA,SPORE,DCTD,,,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA221707,https://trp.cancer.gov/spores/abstracts/mdanderson_gi.htm,,"Gastric Cancer,SPORE",567852
12/28/2023 11:06,12/28/2023 11:07,IP Address,73.130.95.160,100,68,TRUE,12/28/2023 11:07,R_7YlUqCWR4sO0Zr9,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Leukemia  - The University of Texas MD Anderson Cancer Center ,SPORE Leukemia - Texas,SPORE,DCTD,,,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA100632,https://trp.cancer.gov/spores/abstracts/mdanderson_leukemia.htm,,"Leukemia,SPORE",797976
12/28/2023 11:08,12/28/2023 11:09,IP Address,73.130.95.160,100,17,TRUE,12/28/2023 11:09,R_1Ta5LATPtcUFEuB,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Lung Cancer - Fred Hutchinson Cancer Research Center ,SPORE in Lung Cancer - Fred Hutch,SPORE,DCTD,"HOUGHTON, A MCGARRY",,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA228944,,https://trp.cancer.gov/spores/abstracts/fhcrc_lung.htm,"Lung Cancer,SPORE",581522
12/28/2023 11:10,12/28/2023 11:10,IP Address,73.130.95.160,100,9,TRUE,12/28/2023 11:10,R_54eDxN23wAPu9cR,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Lung Cancer - Yale,SPORE in Lung Cancer - Yale,SPORE,DCTD,"HERBST, ROY S",,"Ujhazy, Peter",ujhazyp@mail.nih.gov,,P50CA196530,https://trp.cancer.gov/spores/abstracts/yale_lung.htm,,"Lung Cancer,SPORE",862867
12/28/2023 11:11,12/28/2023 11:11,IP Address,73.130.95.160,100,5,TRUE,12/28/2023 11:11,R_5qg8rzt2VmcWJGB,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Myeloid Malignancies,SPORE in Myeloid Malignancies,SPORE,DCTD,"EBERT, BENJAMIN LEVINE",,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA206963,https://trp.cancer.gov/spores/abstracts/brigham_and_women_leukemia.htm,,"Leukemia,Multiple Myeloma,SPORE",351524
12/28/2023 11:11,12/28/2023 11:11,IP Address,73.130.95.160,100,16,TRUE,12/28/2023 11:11,R_1Yi7tZjw3Bwdhxw,,,,,40.1025,-76.0761,anonymous,EN,ADMIRAL Study: Admixture analysis of acute lymphoblastic leukemia in African American children,ADMIRAL,"Pediatric/AYA,Health Disparities",DCCPS,Logan Spector Ph.D.,spect012@umn.edu,Danielle L. Daee Ph.D. ,danielle.daee@nih.gov,,R01CA239701,https://maps.cancer.gov/overview/DCCPSGrants/abstract.jsp?applId=9995648&term=CA239701,,"Leukemia,Pediatric/AYA,Health Disparities",571518
12/28/2023 11:12,12/28/2023 11:13,IP Address,73.130.95.160,100,19,TRUE,12/28/2023 11:13,R_6JdDDlPzSshMP6N,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Gastrointestinal Cancer -Vanderbilt-Ingram Cancer Center,SPORE in Gastrointestinal Cancer - Vanderbilt,SPORE,DCTD,"COFFEY, ROBERT J",,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA236733,https://trp.cancer.gov/spores/abstracts/vanderbilt_gi.htm,,"Gastric Cancer,SPORE",214884
12/28/2023 11:13,12/28/2023 11:17,IP Address,73.130.95.160,100,224,TRUE,12/28/2023 11:17,R_32W88ZGjquw3A8w,,,,,40.1025,-76.0761,anonymous,EN,Brain Tumor SPORE Grant,SPORE in Brain Cancer - UCSF,SPORE,DCTD,"BERGER, MITCHEL S",,"Hubbard, Leah",leah.hubbard@nih.gov,,P50CA097257,,,"Brain Cancer,SPORE",974215
12/28/2023 11:17,12/28/2023 11:18,IP Address,73.130.95.160,100,19,TRUE,12/28/2023 11:18,R_5D1spRB6xYrjODp,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Hepatocellular Carcinoma - The University of Texas MD Anderson Cancer Center ,SPORE in Hepatocellular Carcinoma,SPORE,DCTD,"BERETTA, LAURA ",,"Nothwehr, Steven F",steve.nothwehr@nih.gov,,P50CA217674,https://trp.cancer.gov/spores/abstracts/mdanderson_hepatobiliary.htm,,"Liver Cancer,SPORE",453824
12/28/2023 11:18,12/28/2023 11:19,IP Address,73.130.95.160,100,48,TRUE,12/28/2023 11:19,R_3EcZbPg2sDXs1mt,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Leukemia- The Memorial Sloan Kettering Cancer Center ,SPORE in Leukemia - MSK,SPORE,DCTD,"ABDEL-WAHAB, OMAR ",,"Kuzmin, Igor A",kuzmini@mail.nih.gov,,P50CA254838,https://trp.cancer.gov/spores/abstracts/mskcc_leukemia.htm,,"Leukemia,SPORE",895984
12/28/2023 11:19,12/28/2023 11:19,IP Address,73.130.95.160,100,5,TRUE,12/28/2023 11:19,R_338nqVzEM4U7PqW,,,,,40.1025,-76.0761,anonymous,EN,SPORE: Targeted Therapies for Glioma,SPORE: Targeted Therapies for Glioma,SPORE,DCTD,"BATCHELOR, TRACY T",,"Hubbard, Leah",leah.hubbard@nih.gov,,P50CA165962,https://trp.cancer.gov/spores/abstracts/brigham_and_women_brain.htm,,"Brain Cancer,SPORE",468366
12/28/2023 11:20,12/28/2023 11:20,IP Address,73.130.95.160,100,4,TRUE,12/28/2023 11:20,R_33v5oFuq82kK3aY,,,,,40.1025,-76.0761,anonymous,EN,SPORE in Bladder Cancer,SPORE in Bladder Cancer,SPORE,DCTD,"BAJORIN, DEAN F",,"Arnold, Julia T",jarnold@mail.nih.gov,,P50CA221745,https://trp.cancer.gov/spores/abstracts/mskcc_bladder.htm,,"Bladder Cancer,SPORE",488472
12/28/2023 11:21,12/28/2023 11:21,IP Address,73.130.95.160,100,29,TRUE,12/28/2023 11:21,R_6FA2UJX3iNHL9SN,,,,,40.1025,-76.0761,anonymous,EN,Acquired Resistance to Therapy Network,ARTNet,"DCC,Cancer Moonshot,Clinical Networks",DCTD,,,"hildesheim, jeff",hildesheimj@mail.nih.gov,RFA-CA-21-052;RFA-CA-21-053,,https://www.nciartnet.org/en/,https://www.nciartnet.org/en/resources/data-sharing-catalog/,This program focuses on cancer broadly - not limited to a primary cancer type,318974
12/28/2023 11:22,12/28/2023 11:26,IP Address,73.130.95.160,100,216,TRUE,12/28/2023 11:26,R_7ltY5pMa4P30Mg5,,,,,40.1025,-76.0761,anonymous,EN,Fusion Oncoproteins in Childhood Cancers (FusOnc2),FusOnc2,"Pediatric/AYA,Cancer Moonshot",DCB,"Keren Witkin, Ph.D.",witkinkeren@mail.nih.gov,"Smith,Malcolm",Malcolm.Smith@nih.gov,RFA-CA-17-049;RFA-CA-19-016,,https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/implementation/childhood-cancer-research#fusion-oncoproteins-in-childhood-cancers-fusonc2-consortium,,"This program focuses on cancer broadly - not limited to a primary cancer type,Pediatric/AYA",984923
12/28/2023 11:27,12/28/2023 11:27,IP Address,73.130.95.160,100,34,TRUE,12/28/2023 11:27,R_13gy2eFwlQ5x5Jg,,,,,40.1025,-76.0761,anonymous,EN,Barrett’s Esophagus Translational Research Network (BETRNet),BETRNet,"DCC,Clinical Networks",DCP,,,"RICHMOND, ELLEN S.; YASSIN, RIHAB R.",er115z@nih.gov,RFA-CA-16-007; RFA-CA-16-006; RFA-CA-10-014,,https://prevention.cancer.gov/major-programs/barretts-esophagus-translational-research-network-betrnet,https://www.vumc.org/cqs/statistical-data-centers,Esophageal Cancer,855838
12/28/2023 11:28,12/28/2023 11:28,IP Address,73.130.95.160,100,7,TRUE,12/28/2023 11:28,R_5I6sFgkwU1755hr,,,,,40.1025,-76.0761,anonymous,EN,Cellular Cancer Biology Imaging Research,CCBIR,,DCB,"PROVENZANO, PAOLO; BACKMAN, VADIM; WIRTZ, DENIS; DANUSER, GAUDENZ",pprovenz@umn.edu; v-backman@northwestern.edu; WIRTZ@JHU.EDU; gaudenz.danuser@utsouthwestern.edu,"BECKER, STEVEN",beckersteven@mail.nih.gov,RFA-CA-21-002,,https://www.cancer.gov/about-nci/organization/dcb/research-programs/ccbir,https://www.cancercomplexity.synapse.org/,This program focuses on cancer broadly - not limited to a primary cancer type,894349
12/28/2023 11:41,12/28/2023 11:55,IP Address,73.130.95.160,100,861,TRUE,12/28/2023 11:55,R_1iEaaT1a8lkfmj9,,,,,40.1025,-76.0761,anonymous,EN,Population-based Research to Optimize the Screening Process,PROSPR,,DCCPS,"LI, CHRISTOPHER I",cili@fredhutch.org,"TUOVINEN, PRIYANGA",tuovinenhr@mail.nih.gov,CA16-017;RFA-CA-16-016,,https://healthcaredelivery.cancer.gov/prospr/,https://healthcaredelivery.cancer.gov/prospr/datashare/,"Cervical Cancer,Colorectal Cancer,Lung Cancer",979823
12/28/2023 12:39,12/28/2023 12:47,IP Address,73.130.95.160,100,527,TRUE,12/28/2023 12:47,R_5htpeOyNZHUd1b5,,,,,40.1025,-76.0761,anonymous,EN,Immuno-Oncology Translation Network,IOTN,Cancer Moonshot,DCB,,,,,RFA-CA-19-012;RFA-CA-19-013;RFA-CA-19-014;RFA-CA-19-015;RFA-CA-17-045;RFA-CA-17-046;RFA-CA-17-047;RFA-CA-17-048;,,https://www.iotnmoonshot.org/en/,https://www.iotnmoonshot.org/en/resources/data-sharing-catalog/,This program focuses on cancer broadly - not limited to a primary cancer type,826706
12/28/2023 12:48,12/28/2023 13:02,IP Address,73.130.95.160,100,894,TRUE,12/28/2023 13:02,R_33f9kL0xWdnu3WX,,,,,40.1025,-76.0761,anonymous,EN,Consortium on Translational Research in Early Detection of Liver Cancer,TLC,DCC,DCP,,,"RINAUDO, JO ANN S.",rinaudoj@mail.nih.gov,RFA-CA-22-031;RFA-CA-22-032;RFA-CA-17-025;RFA-CA-17-028,,https://prevention.cancer.gov/major-programs/translational-liver-cancer-tlc-consortium,,Liver Cancer,657125
12/28/2023 13:03,12/28/2023 13:15,IP Address,73.130.95.160,100,776,TRUE,12/28/2023 13:15,R_3mDkNfVykV0JfOW,,,,,40.1025,-76.0761,anonymous,EN,Connect for Cancer Prevention Study,Connect,,DCEG,,,Mia M. Gaudet,mia.gaudet@nih.gov,,,https://dceg.cancer.gov/research/who-we-study/cohorts/connect,https://github.com/episphere/connect/wiki,This program focuses on cancer broadly - not limited to a primary cancer type,212150
12/28/2023 13:16,12/28/2023 14:10,IP Address,73.130.95.160,100,3266,TRUE,12/28/2023 14:10,R_3j6XJDQyPTKpJtm,,,,,40.1025,-76.0761,anonymous,EN,Childhood Cancer Data Initiative,CCDI,Pediatric/AYA,,,,,,,,https://www.cancer.gov/research/areas/childhood/childhood-cancer-data-initiative,https://ccdi.cancer.gov/home,"This program focuses on cancer broadly - not limited to a primary cancer type,Pediatric/AYA",689190
12/28/2023 14:10,12/28/2023 14:29,IP Address,73.130.95.160,100,1114,TRUE,12/28/2023 14:29,R_7Ugb0CPBJJj7JE1,,,,,40.1025,-76.0761,anonymous,EN,My Pediatric and Adult Rare Tumor Network,MyPART,Pediatric/AYA,CCR,,,"Karlyne M. Reilly, Ph.D.",karlyne.reilly@nih.gov,,,https://www.cancer.gov/pediatric-adult-rare-tumor/,,"This program focuses on cancer broadly - not limited to a primary cancer type,Pediatric/AYA",759169
12/28/2023 14:32,12/28/2023 14:34,IP Address,73.130.95.160,100,100,TRUE,12/28/2023 14:34,R_6f8rVzzDKa5aTJ4,,,,,40.1025,-76.0761,anonymous,EN,National Childhood Cancer Registry,NCCR,Pediatric/AYA,DCCPS,,,Johanna Goderre Jones,johanna.goderrejones@nih.gov,,,https://nccrexplorer.ccdi.cancer.gov/nccr.html,https://nccrexplorer.ccdi.cancer.gov/data-products.html,"This program focuses on cancer broadly - not limited to a primary cancer type,Pediatric/AYA",569319
12/28/2023 14:34,12/28/2023 14:46,IP Address,73.130.95.160,100,698,TRUE,12/28/2023 14:46,R_54OtFYrQMRd6L7j,,,,,40.1025,-76.0761,anonymous,EN,Patient-Derived Xenograft (PDX) Development and Trial Centers Research Network,PDXNet,"Cancer Moonshot,Clinical Networks",DCTD,,,"MOSCOW, JEFFREY ARNOLD",jeffrey.moscow@nih.gov,RFA-CA-17-003;RFA-CA-17-004;RFA-CA-22-012;RFA-CA-22-013,,https://www.pdxnetwork.org/,https://www.pdxnetwork.org/pdccc,This program focuses on cancer broadly - not limited to a primary cancer type,262206
12/28/2023 14:50,12/28/2023 14:52,IP Address,73.130.95.160,100,115,TRUE,12/28/2023 14:52,R_6fSfRrkxe8ZbPpL,,,,,40.1025,-76.0761,anonymous,EN,Pediatric Early Phase Clinical Trials Network,PEP-CTN,"Pediatric/AYA,Cancer Moonshot,Clinical Networks",DCTD,,,Malcolm A. Smith,Malcolm.Smith@nih.gov,RFA-CA-12-502;RFA-CA-17-027;RFA-CA-24-007,,https://ctep.cancer.gov/initiativesPrograms/pep-ctn.htm,,"This program focuses on cancer broadly - not limited to a primary cancer type,Pediatric/AYA",565522
12/29/2023 7:01,12/29/2023 7:05,IP Address,73.130.95.160,100,207,TRUE,12/29/2023 7:05,R_1WT4Owcb1JYKZMT,,,,,40.1025,-76.0761,anonymous,EN,The Therapeutically Applicable Research to Generate Effective Treatments,TARGET,Pediatric/AYA,CCG,,,"SMITH, MALCOLM",smithm@ctep.nci.nih.gov,,,https://www.cancer.gov/ccg/research/genome-sequencing/target,https://www.cancer.gov/ccg/,"Brain Cancer,Kidney Cancer,Leukemia,Osteosarcoma,Pediatric/AYA",786965
1/4/2024 4:46,1/4/2024 4:52,IP Address,73.130.95.160,100,349,TRUE,1/4/2024 4:52,R_3cdsEdbXqxzjL2V,,,,,40.1025,-76.0761,anonymous,EN,ADVANCED DEVELOPMENT OF INFORMATICS TECHNOLOGIES FOR CANCER RESEARCH AND MANAGEMENT,ITCR,"DCC,Clinical Networks",NIH/OD,"Klemm, Juli",,,juli.klemm@nih.gov,PAR15-331;PAR-15-332;PAR15-333;PAR-15-334;RFA-CA-19-040;RFA-CA-20-009;RFA-CA-19-038;RFA-CA-20-007;RFA-CA-19-039;RFA-CA-20-008;RFA-CA-19-041;RFA-CA-20-010;RFA-CA-19-042;RFA-CA-20-060;RFA-CA-21-013;RFA-CA-21-014;RFA-CA-21-015;RFA-CA-21-016;RFA-CA-21-017;RFA-CA-21-018;RFA-CA-21-019;RFA-CA-22-023;RFA-CA-22-021;RFA-CA-22-022;RFA-CA-22-024;RFA-CA-23-014;RFA-CA-23-015;RFA-CA-23-016;RFA-CA-23-017,,https://itcr.cancer.gov/about-itcr,https://itcr.cancer.gov/informatics-tools,This program focuses on cancer broadly - not limited to a primary cancer type,595982
1/4/2024 4:53,1/4/2024 7:07,IP Address,73.130.95.160,100,8036,TRUE,1/4/2024 7:07,R_36BXfM0MtJ901dD,,,,,40.1025,-76.0761,anonymous,EN,All of Us,All of Us,DCC,NIH/OD,,help@joinallofus.org,,,RFA-HG-21-041;NOT-OD-15-159;OTA-17-002;OTA-18-001;OTA-19-002;OTA-19-003;OTA-19-004;OTA-20-001;OTA-20-009;OTA-22-006;OTA23-001;OTA-23-002;OTA-23-003;OT-PM-16-002;OT-PM-16-003;OT-PM-17-002;OT-PM-18-002;OT-PM-18-003;OT-PM-19-001;OT-PM-20-001;RFA-HG-23-018;RFA-LM-21-002;RFA-PM-16-001;RFA-PM-16-002;RFA-PM-16-003;RFA-PM-23-001;RFA-PM-23-002;RFA-RM-21-001;RFA-RM-21-002;RFA-RM-21-003;RFA-RM-21-004;RFA-RM-21-005;RFA-RM-21-006,,https://allofus.nih.gov/,https://www.researchallofus.org/,This program focuses on cancer broadly - not limited to a primary cancer type,757670
1/4/2024 7:08,1/4/2024 7:08,IP Address,73.130.95.160,100,32,TRUE,1/4/2024 7:08,R_1FK9pA9Q6uZjMfz,,,,,40.1025,-76.0761,anonymous,EN,Childhood Cancer Survivor Study,CCSS,"Pediatric/AYA,DCC,Clinical Networks","CIB,CTEP,DCEG","ARMSTRONG, GREGORY; Seibel, Nita",greg.armstrong@stjude.org; seibelnl@mail.nih.gov,"TIMMER, WILLIAM C.",timmerw@mail.nih.gov,RFA-CA-20-052;RFA-CA-15-502,,https://ccss.stjude.org/,https://ccss.stjude.org/public-access-data.html,"This program focuses on cancer broadly - not limited to a primary cancer type,Pediatric/AYA",524000
1/4/2024 7:09,1/4/2024 7:09,IP Address,73.130.95.160,100,36,TRUE,1/4/2024 7:09,R_1pVFUxYb8bxIFah,,,,,40.1025,-76.0761,anonymous,EN,Clinical Proteomic Tumor Analysis Consortium,CPTAC,"Pediatric/AYA,DCC",DCTD,,,"HILTKE, TARA",hiltket@mail.nih.gov,RFA-CA-15-023;RFA-CA-15-021;RFA-CA-21-024;RFA-CA-21-023,,https://proteomics.cancer.gov/programs/cptac,"https://gdc.cancer.gov/about-gdc/contributed-genomic-data-cancer-research/clinical-proteomic-tumor-analysis-consortium-cptac#:~:text=The%20National%20Cancer%20Institute%27s%20Clinical,and%20genome%20analysis%2C%20or%20proteogenomics.","This program focuses on cancer broadly - not limited to a primary cancer type,Pediatric/AYA",903892
1/4/2024 7:10,1/4/2024 7:10,IP Address,73.130.95.160,100,44,TRUE,1/4/2024 7:11,R_1MipxFHkYEwaHco,,,,,40.1025,-76.0761,anonymous,EN,Partnerships to Advance Cancer Health Equity (PACHE),PACHE,"Cancer Center,Health Disparities",CRCHD,,,"Rodriguez, Laritza; Wali, Anil; Davani, Behrous ",laritza.rodriguez@nih.gov,PAR-18-767;PAR-22-249;PAR-22-239;PAR-18-911;PAR-18-361,,https://www.cancer.gov/about-nci/organization/crchd/diversity-training/pache,,"This program focuses on cancer broadly - not limited to a primary cancer type,Health Disparities",899007
1/4/2024 7:11,1/4/2024 7:12,IP Address,73.130.95.160,100,47,TRUE,1/4/2024 7:12,R_5jePwPV2iDqqEUE,,,,,40.1025,-76.0761,anonymous,EN,CTD^2: Cancer Target Discovery and Development,CTD^2,"Pediatric/AYA,DCC",CCG,,,"Komschlies Mcconvill, Kristin",ocg@mail.nih.gov,RFA-CA-16-014;PAR-21-274,,https://www.cancer.gov/ccg/research/functional-genomics/ctd2,https://www.cancer.gov/ccg/research/functional-genomics/ctd2/data-portal,"This program focuses on cancer broadly - not limited to a primary cancer type,Pediatric/AYA",996219
1/4/2024 7:29,1/4/2024 7:30,IP Address,73.130.95.160,100,31,TRUE,1/4/2024 7:30,R_78UI6ZZO9P1SstH,,,,,40.1025,-76.0761,anonymous,EN,Human Tumor Atlas Network ,HTAN ,"Pediatric/AYA,DCC,Cancer Moonshot",DCP,,,"Shannon Hughes, Ph.D.",Shannon.Hughes@nih.gov,RFA-CA-17-036;RFA-CA-17-034;RFA-CA-17-035;RFA-CA-20-042;RFA-CA-21-037,,https://humantumoratlas.org/,https://humantumoratlas.org/explore,"This program focuses on cancer broadly - not limited to a primary cancer type,Pediatric/AYA",108262
